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Abbreviations 
 
13C6-SMZ Sulfamethoxazole (Ring-13C6) 
ANOVA  Analysis of variance 
CBZ  Carbamazepine 
CBZ-d10 Carbamazepine-d10 
CBZ-DiOH 10,11-Dihydro-10,11-dihydroxy-carbamazepine 
CRM  Certified reference material 
GC  Gas chromatography 
HLB  Hydrophilic-lipophilic-balanced 
IS  Internal standard 
ISO  International Organisation for Standards 
LoD  Limit of detection 
LoQ  Limit of quantification 
MRM   Multiple reaction monitoring 
MS  Mass spectrometry 
13C4-PFBA Perfluoro-n-[1,2,3,4-13C4] butanoic acid 
PFPrA  Pentafluoropropionic acid 
PS  Priority Substances 
R2  Regression coefficient 
RSD  Relative standard deviation 
SD  Standard deviation 
SIM  Selected ion monitoring 
SMZ  Sulfamethoxazole 
SPE  Solid phase extraction 
TBP-d27  Tris-n-butyl-d27 phosphate 
TCPP  Tris (1-chloro-2-propyl) phosphate 
UHPLC  Ultra high pressure liquid chromatography 
WAX  Weak anion exchange 
WFD  Water Framework Directive 
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Introduction 
The Water Framework Directive (WFD) 2000/60/EC (Article 16(4)) requires that the list of Priority 
Substances (PS) be reviewed at least every four years. PS are defined as substances presenting a 
significant risk to or via the aquatic environment at EU level. In order to assess risk, both hazard 
and exposure need to be considered. However, exposure data (environmental concentrations) may 
be available only in a limited geographical area, especially if a substance is not regulated. The 
“watch list” mechanism has been included in the new amended Environmental Quality Standards 
Directive under the WFD. It will ensure the targeted collection of monitoring data for emerging 
pollutants for the purpose of risk assessment, to support future reviews of the priority substance 
list. It will contain a limited number of substances (maximum up to 25) of emerging concern which 
will be monitored in a limited number of representative monitoring stations across Europe, to gain 
high-quality information on their occurrence fit for purpose for prioritization under the WFD. The 
list should be dynamic, to respond to new information on the potential risks posed by emerging 
pollutants and avoid monitoring substances for longer than necessary. Monitoring matrices will be 
water, sediment, or biota. 
In order to contribute to the discussion and to explore how such a watch list could be organised 
technically and logistically, the Expert Group on Chemical Monitoring and Emerging Pollutants 
(CMEP) organised during 2012 a pilot exercise using the infrastructure and support provided by 
the European Commission’s Joint Research Centre (JRC). The scope of this pilot exercise was to 
assess how to provide information on the presence and concentrations of selected substances of 
“watch list potential” using a representative EU-wide sub-set of WFD monitoring stations (ca. 250) 
and relying on existing infrastructure. The question of how to quickly provide suitable analytical 
protocols as pre-normative input, with the aim of shortening the necessary standardisation 
process, was also addressed. 
In the context of the pilot exercise the following method validation contributed to the execution of 
chemical analysis of a subset of identified pilot substances (carbamazepine (CBZ), 10,11-dihydro-
10,11-dihydroxy-carbamazepine (CBZ-DiOH), sulfamethoxazole (SMZ), penta-fluoropropionic acid 
(PFPrA) and tris (1-chloro-2-propyl) phosphate (TCPP)) in surface water samples. 
CBZ-DiOH, the hydroxylated metabolite of CBZ, has been detected in waste and surface water at a 
higher concentration than the parent compound (De Laurentiis et al., 2012; Fenet et al., 2012; 
Hummel et al., 2006; Miao and Metcalfe, 2003). 
CBZ, CBZ-DiOH, SMZ, and TCPP were extracted from 1L water using solid-phase extraction (SPE) 
with OASIS HLB adsorbent; elution was performed with ethylacetate. In contrast, PFPrA was 
extracted from 100 mL water using OASIS WAX cartridges (weak anion exchanger) and elution 
was performed with 0.1% ammonia in methanol. Determination of CBZ, CBZ-DiOH, SMZ, and 
PFPrA was conducted with LC-MS/MS, and TCPP with GC-MS.  
This validation report will be integrated into the full study report of the pilot exercise and used for 
the assessment of the feasibility and difficulties encountered. 
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1. Materials and methods  
1.1. Chemicals  
1.1.1. Standards 
Carbamazepine (CAS 298-46-4), lot 100M1207V, purity (TLC) 100%, retest date October 2016, 
code C4024, Sigma Aldrich, MO (USA); 
Carbamazepine-d10 100 µg/mL in acetonitrile–d3, lot SCJK-006, purity ≥ 98%, expiry date May 
2015, code DLM-2806-S, Cambridge Isotope Laboratories, Inc., Andover, MA (USA); 
10,11-Dihydro-10,11-dihydroxy-carbamazepine, lot 1071-050A1, purity 99.9%, retest date May 
2015, Spectra 2000 SrL, Rome (Italy); 
Sulfamethoxazole (CAS 723-46-6), lot 80416, purity 99.5 ± 0.5%, Dr. Ehrenstorfer, Augsburg 
(Germany); 
13C6-Sulfamethoxazole (Ring-13C6, 99%) 100 µg/mL in acetonitrile, lot SCJI-015, purity ≥ 98%, 
expiry date October 2019, code CLM-6944-S, Cambridge Isotope Laboratories, Inc., Andover, MA 
(USA); 
Pentafluoropropionic acid (CAS 422-64-0), lot 78896PM, purity 98.9%, density 1.56 g/mL, release 
date March 2011, code 245917, Sigma Aldrich, MO (USA); 
13C4-Perfluoro-n-[1,2,3,4-13C4] butanoic acid, 50±2.5 µg/mL, lot MPFBA0911, purity >99% 
13C(1,2,3,4-13C4), expiry date September 2014, code MPFBA, Wellington Laboratories, Guelph, 
Ontario, Canada; 
Tri-n-butyl-d27 phosphate (Product No. 9491.12-100-IO), Chiron AS (Norway); 
Tris(1-chloro-2-propyl)phosphate, 50 µg/mL in toluene, LOT: 209071282, AccuStandard, Inc. 
(USA). 
1.1.2. Materials and reagents 
Ethyl acetate for trace analysis (Carlo Erba Reactifs-SDS); 
Methanol, code 701091.1612, (LC-MS) PAI, Panreac Quimica, Barcelona (Spain); 
MilliQ water obtained from a MilliQ water system, Millipore, Bedford, MA (USA); 
Hexane for analysis of dioxins, furans and PCB (Sigma-Aldrich, Germany); 
Ammonium acetate 99.99+%, code 431311, Sigma Aldrich, MO (USA); 
Acetonitrile, code 701881.1612, (LC-MS) PAI, Panreac Quimica, Barcelona (Spain); 
Acetic acid, code 07692, TraceSelectUltra for trace analysis, Sigma Aldrich, MO (USA); 
Ammonium hydroxide, 28% in water, 99.99% metals basis, code 338818, Sigma Aldrich, 
Germnay; 
OASIS HLB cartridges 6CC (0.2 g), code WAT106202, Waters, Milford, MA, USA; 
OASIS WAX cartridges 6 CC (0.15 g), code 186002493, Waters, Milford, MA USA. 
 10 
 
1.1.3. Preparation of reagent solutions 
1.1.3.1. 25 mM acetic acid (for OASIS WAX) 
• 1.4 mL of glacial acetic acid was transferred into a 1 L volumetric flask and 
• diluted to the volume with water. 
1.1.3.2. 25 mM ammonium acetate (for OASIS WAX) 
• 1.92 g of ammonium acetate was weighed into a 1 L volumetric flask, then 
• dissolved and diluted to the volume with water. 
1.1.3.3. 25 mM acetate buffer pH4 (for OASIS WAX) 
• 600 mL of 25 mM acetic acid and 300 mL of 25 mM ammonium acetate were combined 
into a 1 L volumetric flask, then 
• mixed and degased under vacuum in ultrasonic bath for 20 sec. 
1.1.3.4. 0.1% ammonia in methanol (for OASIS WAX) 
• 4.48 mL of ammonium hydroxide 28% was transferred into a 1 L volumetric flask, then 
• diluted to the volume with methanol and 
• mixed and degased under vacuum in ultrasonic bath for 20 sec. 
1.1.3.5. Mobile phase A: 5 mM ammonium acetate  
• 0.385 g of ammonium acetate was weighed into a 1 L volumetric flask, then 
• dissolved and diluted to the volume with water. 
1.1.3.6. Mobile phase B: methanol:acetonitrile 50:50 % (v/v) 
• 500 mL of methanol and 500 mL of acetonitrile were transferred into a 1 L bottle, then 
• mixed and degased under vacuum in ultrasonic bath for 20 sec. 
1.1.3.7. UHPLC autosampler weak washing solutions 
• 900 mL of water, 47.5 mL of methanol, 47.5 mL of acetonitrile and 5 mL of glacial acetic 
acid were transferred into a 1 L bottle, then 
• mixed and degased under vacuum in ultrasonic bath for 20 sec. 
1.1.3.8. UHPLC autosampler strong washing solutions 
• 45 mL of water, 475 mL of methanol, 475 mL of acetonitrile and 5 mL of glacial acetic acid 
were transferred into a 1 L bottle, then 
• mixed and degased under vacuum in ultrasonic bath for 20 sec. 
1.1.3.9. UHPLC seal washing solutions 
• 100 mL of methanol and 900 mL of water were transferred into a 1 L bottle, then 
• mixed and degased under vacuum in ultrasonic bath for 20 sec. 
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1.1.3.10. UHPLC-MS/MS reconstituting solution for LC-MS/MS analysis 
• 900 mL of mobile phase A and 100 mL of mobile phase B were transferred into a 1 L bottle 
and mixed. 
1.1.4. Preparation of standard solutions 
1.1.4.1. CBZ stock standard solution (1000 µg/mL) 
• 10 mg of CBZ was weighed into a 10 mL volumetric flask, then 
• dissolved and diluted to volume with methanol and mixed. 
1.1.4.2. CBZ-DiOH stock standard solution (1000 µg/mL) 
• 10 mg of CBZ-DIOH was weighed into a 10 mL volumetric flask, then 
• dissolved and diluted to volume with methanol and mixed. 
1.1.4.3. SMZ stock standard solution (1000 µg/mL) 
• 10 mg of SMZ was weighed into a 10 mL volumetric flask, then 
• dissolved and diluted to volume with methanol and mixed. 
1.1.4.4. Intermediate standard solution 1 (CBZ, CBZ-DiOH, SMZ 1 µg/mL) 
• 10 µL of CBZ, CBZ-DiOH and SMZ stock standard solutions (1000 µg/mL) were transferred 
into a 10 mL volumetric flask, then 
• diluted to volume with methanol and mixed. 
1.1.4.5. Intermediate standard solution 2 (CBZ, CBZ-DiOH, SMZ 10 ng/mL) 
• 0.1 mL of CBZ, CBZ-DiOH and SMZ intermediate standard solution 1 (1 µg/mL) were 
transferred into a 10 mL volumetric flask, then 
• diluted to volume with methanol and mixed. 
1.1.4.6. TCPP working standard solution (1 µg/mL) 
• 0.2 mL of TCPP standard solution (50 µg/mL) was transferred into a 10 mL volumetric 
flask, then 
• diluted to volume with acetone:methanol 50:50 % (v/v) and mixed. 
1.1.4.7. Standard solution A (CBZ, CBZ-DiOH, SMZ: 0.2 ng/mL, TCPP 10 ng/mL) 
• 20 µL of intermediate standard solution 2 was transferred into a 1 mL dark vial, then 
• 1 µL of TCPP working solution was added and after 
• diluted to 1 mL with acetone:methanol 50:50 % (v/v) and mixed. 
1.1.4.8. Standard solution B (CBZ, CBZ-DiOH, SMZ, 1 ng/mL, TCPP 25 ng/mL) 
• 0.1 mL of intermediate standard solution 2 was transferred into a 2 mL dark vial, then 
• 25 µL of TCPP working solution was added and after  
• diluted to 1 mL with acetone:methanol 50:50 % (v/v) and mixed. 
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1.1.4.9. Standard solution C (CBZ, CBZ-DiOH, SMZ, 2 ng/mL, TCPP 50 ng/mL). 
• 0.2 mL of intermediate standard solution 2 was transferred into a 2 mL dark vial, then 
• 50 µL of TCPP working solution was added and 
• diluted to 1 mL with acetone:methanol 50:50 % (v/v) and mixed. 
1.1.4.10. Standard solution D (CBZ, CBZ-DiOH, SMZ, 40 ng/mL, TCPP 200 ng/mL) 
• 40 µL of intermediate standard solution 1 was transferred into a 2 mL dark vial, then 
• 0.2 mL of TCPP working solution was added and 
• diluted to 1 mL with acetone:methanol 50:50 % (v/v) and mixed. 
1.1.4.11. Standard solution E (CBZ, CBZ-DiOH, SMZ, 100 ng/mL, TCPP 500 ng/mL) 
• 0.1 mL of intermediate standard solution 1 was transferred into a 2 mL dark vial, then 
• 0.5 mL of TCPP working solution was added and 
• dilute to 1 mL with acetone:methanol 50:50 % (v/v) and mixed. 
1.1.4.12. Standard solution low QC (CBZ, CBZ-DiOH, SMZ, 3 ng/mL, TCPP 30 ng/mL) 
• 0.3 mL of intermediate standard solution 2 was transferred into a 2 mL dark vial, then 
• 30 µL of TCPP working solution was added and 
• diluted to 1 mL with acetone:methanol 50:50 % (v/v) and mixed. 
1.1.4.13. Standard solution high QC (CBZ, CBZ-DiOH, SMZ, 90 ng/mL, TCPP 300 
ng/mL) 
• 0.09 mL of intermediate standard solution 1 was transferred into a 2 mL dark vial, then 
• 0.3 mL of TCPP working solution was added and 
• diluted to 1 mL with acetone:methanol 50:50 % (v/v) and mixed. 
1.1.4.14. PFPrA stock standard solution (1000 µg/mL) 
• 6.4 µL of PFPrA was transferred into a 10 mL volumetric flask, then 
• dissolved and diluted to volume with water and mixed. 
1.1.4.15. PFPrA intermediate standard solution 1 (10 µg/mL) 
• 10 µL of PFPrA stock standard solution was transferred into a 10 mL volumetric flask, then 
• dissolved and diluted to volume with water and mixed. 
1.1.4.16. PFPrA intermediate standard solution 2 (500 ng/mL) 
• 1 mL of PFPrA stock standard solution was transferred into a 20 mL volumetric flask, then 
• dissolved and diluted to volume with water and mixed. 
1.1.4.17. PFPrA intermediate standard solution 3 (100 ng/mL) 
• 1 µL of PFPrA stock standard solution was transferred into a 10 mL volumetric flask, then 
• dissolved and diluted to volume with water and mixed. 
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1.1.4.18. PFPrA intermediate standard solution 4 (10 ng/mL) 
• 0.1 mL of PFPrA stock standard solution was transferred into a 10 mL volumetric flask, 
then 
• dissolved and diluted to volume with water and mixed. 
1.1.4.19. Internal standard working solution (CBZ-d10 and 13C6-SMZ ,1 µg/mL) 
• 0.1 mL of CBZ-d10 100 µg/mL and 0.1 mL of 13C6-SMX 100 µg/mL were transferred into a 
10 mL volumetric flask, then 
• diluted to 10 mL with methanol and mixed. 
1.1.4.20. Internal standard working solution (TBP-d27, 10 µg/mL) 
• 1.0 mL of TBP-d27 100 µg/mL was transferred into a 10 mL volumetric flask, then 
• diluted to 10 mL with hexane and mixed. 
1.1.4.21. Internal standard working solution (13C4-PFBA, 50 ng/mL) 
• 0.5 mL of 13C4-PFBA 100 µg/mL was transferred into a 10 mL volumetric flask, then 
• diluted to 10 mL with methanol and mixed. 
1.2. Apparatus 
1.2.1. Laboratory equipment 
Analytical balance: Model AX204, Mettler-Toledo SpA; 
Automatic pipettes: Eppendorf research (Milan, Italy); 
Microsyringes: Microliter Syringes, Hamilton (Reno, CA, U.S.A.); 
Autosampler vials for GC-MS: V-Vial 11 mm, Vol. 1,5 mL, 12 x 32 mm (code ARO-3741-12) with 
11 mm 0.040” PTFE/Silicone Septa silver crimp cap (code ARO-
5750-13), Phenomenex (United Kingdom); 
Autosampler vials for LC-MS: Micro-V vials target Dp clear, 2 mL, 12x22 mm, National Scientific 
(Germany); 
Volumetric flasks: Grade A, various sizes, Duran®; 
Volumetric pipettes: Grade A, various sizes, Duran®; 
Dionex Autotrace AT280 automated SPE system (Thermo Scientific, Waltham, MA, USA); 
TurboVap II (Caliper Life Science, Mountain View, CA, USA); 
Vortex Genius, Ika, Staufen, Germany. 
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1.2.2. Instrumental equipment and conditions 
1.2.2.1. UHPLC equipment and conditions  
The technical information and the working conditions of the UHPLC system are shown in the 
following Table 1 and the elution gradient scheme used in the Table 2 below. 
Table 1 Equipment and conditions of UHPLC system 
Pumps: Binary Solvent Manager, Model UPB, Waters (Milford, MA, USA). 
Autosampler: Sample Manager, Model UPA, Waters (Milford, MA, USA). 
Detector: QTRAP 5500, Applied Biosystems MDS SCIEX, (Foster City, CA, U.S.A) equipped with Turbo V™ ion source. 
Flow rate: 400 µL/min 
Injection volume: 5 µL 
Analytical 
column: 
Triart C18, 1.9 µm, 50 x 2.1 mm, YMC (Dinslaken, Germany) equipped with 
UHPLC column saver (Fortis, Technologies) 
Mobile phase: 5 mM ammonium acetate – acetonitrile -methanol (90:5:5 % (v/v/v)) 
Table 2 Gradient mode scheme of UHPLC system 
Time (min) A B Flow (mL/min) 
0 90 10 0.4 
1 90 10 0.4 
9 5 95 0.4 
9.1 5 95 0.4 
9.2 90 10 0.4 
12 90 10 0.4 
Under these conditions the retention times of CBZ, CBZ-DiOH, SMZ and PFPrA were about 6.0, 
4.6, 2.9 and 1.3 min, respectively. The run time was about 12.5 min. 
1.2.2.2. QTRAP 5500 operative condition  
An AB Sciex QTRAP 5500 mass spectrometer equipped with Turbo V™ ion source was used. The 
instrument was previously tuned and calibrated in electrospray mode using PPG's. Prior to 
analysis, all the specific parameters were optimised infusing a 1 µg/mL standard solution of 
analytes and ISs. The instrument was run (for quantification) in the MRM MS-MS mode. 
The eluent from the column was introduced directly into the ion source. The rapid desolvation and 
vaporization of the droplets minimizes thermal decomposition and preserved their molecular 
identity. 
The data were collected using the software program Analyst 1.5.1. 
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All calculations were based on chromatographic peak area ratios for the MRM precursor-product 
ion transitions for analytes versus ISs. 
The general operating conditions of QTRAP are shown in the following Table 3 
Table 3 Operating conditions of QTRAP 5500 
Scan Type: Scheduled MRM 
Polarity: Positive for CBZ, CBZ-DiOH and SMZ 
Ion Source: Turbo Spray 
Resolution Q1: Unit 
Resolution Q3: Unit 
MR Pause: 5.0000 msec 
 
Analyte Time(min) DP CE 
CBZ (237>194) 6 250 28 
CBZ (237>165) 6 250 60 
CBZ-DiOH (271>180) 4.6 80 47 
CBZ-DiOH (271>180) 4.6 80 19 
SMZ (254>156) 2.9 150 22 
SMZ (254>156) 2.9 150 38 
 
CUR: 25.00 
CAD: Medium 
TEM: 550.00 
IS: +4500.00 
EP +10.00 
CXP +13.00 
GS1 55 
GS2 45 
 
Scan Type: Scheduled MRM 
Polarity: Negative for PFPrA 
Ion Source: Turbo Spray 
Resolution Q1: Unit 
Resolution Q3: Unit 
MR Pause: 5.0000 msec 
 
Analyte Time(min) DP CE 
PFPrA (163>119) 1.3 -113 -20 
PFPrA (163>69) 1.3 -113 -45 
 
CUR: 25.00 
CAD: Medium 
TEM: 550.00 
IS: -4500.00 
EP -10.00 
CXP -11.00 
GS1 55 
GS2 45 
1.2.2.3. GC-MS equipment and conditions 
The technical information and the working conditions of the GC-MS system are shown in the 
following Table!4. 
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Table 4 Equipment and conditions of GC-MS system 
GC Agilent 6890 N    
Column: SGE-BPX-50    
Nominal length: 60 m    
Nominal Diameter: 250 µm    
Nominal film thick-
ness: 0.25 µm    
Gas Type Helium    
Mode: constant flow    
Initial flow: 1 mL/min    
Oven:     
Initial Temperature: 80 ͦC    
Initial Time: 1 min    
Ramps: # Rate Final Temp 
Final 
Time 
 1 30 ͦC/min 180 ͦC 0   min 
 2 10 ͦC/min 300 ͦC 15 min 
Run Time 31.33 min    !
Front Inlet (CIS4)     
Mode Splitless    
Initial Temperature 250 ͦC    
Pressure 180 kPa    
Purge Flow 100 mL/min    
Purge Time 1 min    
Total Flow 104.1 mL/min    !
Gerstel CIS 4     
Initial Temperature 80 ͦC    
Equilibration Time 0.05 min    
Initial Time 0.10 min    
Rate 10  ͦC/sec    
Final Temp 280  ͦC    
Hold Time 10 min    !
MS 
Agilent 5973 
Mass Selective 
Detector 
   
Mode EI    
MS Quad 150  ͦC    
MS Source 230  ͦC    
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2. Preparation of calibration standards and QC samples 
2.1. Calibration standards and QC samples for CBZ, CBZ-DiOH, SMZ and 
TCPP 
• 1 L glass bottle was filled with 1L MilliQ water and 
• 1 mL of working standard solutions were added according to the following scheme shown 
in Table 5: 
Table 5 Scheme of calibration standards and QC samples for CBZ, CBZ-DiOH, SMZ and TCPP 
Working 
solution 
CBZa, CBZ-DiOHa, 
SMZa, TCPPb 
concentration 
ng/mL 
CBZ, CBZ-DiOH, SMZ, 
concentration in water 
ng/L 
Sample type 
A 0.2a, 10b 0.2a, 10b Calibration samples 
B 1a, 25 b 1a, 25 b „ 
C 2 a, 50 b 2 a, 50 b „ 
D 40 a, 100b 40 a, 100b „ 
E 100 a, 500 b 100 a, 500 b „ 
Low QC 3a, 30b 3a, 30b QC samples 
High QC 90a, 300b 90a, 300b „ 
2.2. Preparation of water samples for CBZ, CBZ-DiOH, SMZ and TCPP 
• 10 µL of IS working solution of CBZ-d10, 13C6-SMZ and TBPd27 were added to 1 L water 
standard and QC samples. 
• Samples were shaken. 
• SPE OASIS HLB cartridges were conditioned with 10 mL of ethyl acetate. 
• SPE cartridges were conditioned with 10 mL of methanol. 
• SPE cartridges were conditioned with 10 mL of water. 
• Water samples were loaded at flow 10 mL/min. 
• Sorbent was dried under nitrogen flow for 30 min. 
• Samples were eluted with 10 mL ethyl acetate at flow 5 mL/min. 
Half of received extract (i.e. about 5 mL) was evaporated to dryness and reconstituted in 0.2 mL 
of reconstituting solution for LC-MS/MS analysis. The remaining aliquot (i.e. about 5 mL) was 
evaporated to 50-100 µL under nitrogen flow for GC-MS determination. 
2.3. Preparation of calibration standards and QC samples for PFPrA 
• 1 L glass bottle was filled with 0.1L MilliQ water. 
• Working standard solutions were added according to the following scheme shown in Table 
6: 
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Table 6 Scheme of calibration standards and QC samples for PFPrA 
Working 
solution 
PFPrA 
concentration 
ng/mL 
Added 
volume (mL) 
PFPrA, concentration 
in water 
ng/L 
Sample type 
Intermediate 
solution 2 10 0.01 1 
Calibration 
samples 
Intermediate 
solution 2 10 0.05 5 „ 
Intermediate 
solution 3 50 0.02 10 „ 
Intermediate 
solution 3 50 0.04 20 „ 
Intermediate 
solution 4 500 0.02 100 „ 
Intermediate 
solution 2 500 0.04 200  
Low QC 10 0.3 3 QC samples 
High QC 500 0.3 150 „ 
2.4. Preparation of water samples for PFPrA 
The analytical method for PFPrA was adapted from the methods published by Li et al. (2010) and 
Taniyasu et al. (2005; 2008), and ISO method 25101 (2009).  
• 10 µL of IS working solution of 13C4-PFBA was added to 0.1 L water standard and QC 
samples. 
• Samples were shaken. 
• SPE OASIS WAX cartridges were conditioned with 4 mL of 0.1% ammonia in methanol. 
• SPE cartridges were conditioned with 4 mL of methanol. 
• SPE cartridges were conditioned with 4 mL of water. 
• Water samples were loaded at flow 10 mL/min 
• Cartridges were washed with 4 mL 25 mM acetate buffer pH 4. 
• Sorbent was dried under nitrogen for 20 min. 
• Samples were eluted with 4 mL of 0.1% ammonia in methanol. 
The extract was evaporated to dryness and reconstituted in 200 µL of reconstituting solution for 
LC-MS/MS analysis. 
3. Validation procedure and results 
Validation was carried out according to the ISO 17025 standard. During the validation process 
following parameters were evaluated: selectivity, method linearity and working range, recovery, 
limits of detection and quantification, trueness, repeatability, reproducibility and intermediate 
precision. Finally the relative combined standard uncertainty was estimated. 
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3.1. Selectivity 
3.1.1. CBZ, CBZ-DiOH, SMZ, PFPrA and corresponding standards 
For the identification of CBZ, CBZ-DiOH, SMZ and PFPrA two MRM transitions between the 
precursor ions and two most abundant fragment ions were monitored. The first one was used for 
quantification purposes, whereas the second one was to confirm the presence of the target 
compounds in the sample. The quantified analyte was identified through retention time comparison 
of the corresponding standard and the isotopic ratio between two ions recorded (±30%), in 
comparison to the standard. 
The selected mass transitions used for quantification were 237/194 for CBZ, 271/180 for CBZ-
DiOH, 254/156 for SMZ, 247/204 for CBZ-d10, 260/98 for 13C6-SMZ, 163/119 for PFPrA and 
217/172 for 13C4-PFBA. 
3.1.2. TCPP and corresponding standard 
TCPP (sum of three isomers) was identified in SIM (Selected Ion Monitoring) mode, recording the 
following ion traces: 277 and 279 amu (two isotopic ions of the cluster Cl). The quantified analyte 
was identified through retention time comparison of the corresponding standard and the isotopic 
ratio between two ions recorded (±20%). 
For TBP-d27 identification following ion traces were monitored: 103 amu and 167 amu. 
3.2. Limit of Detection (LoD) and Limit of Quantification (LoQ) 
Limits of detection and quantification were estimated by analysing blank samples. From the data 
achieved from these experiments (n = 5-7) the mean value of the blank samples (b) and standard 
deviation (SD) were calculated. LoD and LoQ were estimated using the following formulas, 
recommended by Eurachem Guide (Eurachem Group, 1998). 
LOD=b+3SD; 
LOQ=b+10SD. 
The results of the LoD and LoQ estimation for every analyte are shown in the Table!7. 
Table 7 LoD and LoQ values for analytes 
Analyte 
Nr of 
blanks 
analyzed 
LoD 
(ng/L) 
LoQ 
(ng/L) 
CBZ 5 0.03 0.07 
CBZ-DiOH 5 0.10 0.26 
SMZ 5 0.05 0.13 
TCPP 7 2.00 4.00 
PFPrA 5 0.59 1 
3.3. Linearity study 
3.3.1. Linearity study for CBZ, CBZ-DiOH and SMZ 
For CBZ, CBZ-DiOH and SMZ the linearity was studied in the concentration range 0.2-100 ng/L. 
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In order to verify the linearity of the calibration curve, a blank sample spiked only with labelled 
internal standard and five spiked MilliQ water samples (i.e.: 0, 0.2, 1, 2, 40, 100 ng/L) were 
extracted and analyzed in three replicates on five different days. The calibration curves are 
reported in Annex 1: Figure 1 for CBZ, Figure 3 for CBZ-DiOH and Figure 5 for SMZ. 
As reported in Table 8, the mean coefficient of determination (R2) values, calculated over five 
calibration curves, were ≥0.99 for every analyte, with RSD% of 0.4, 0.6 and 0.9 for CBZ, CBZ-
DiOH and SMZ, respectively. 
Table 8 Coefficient of determination (R2) values for CBZ, CBZ-DiOH and SMZ calibration curves on 
different days 
Validation day CBZ CBZ-DiOH SMZ 
1 1.0000 0.9962 0.9988 
2 0.9993 0.9991 0.9986 
3 0.9988 0.9893 0.9977 
4 0.9993 0.9868 0.9991 
5 0.9900 0.9860 0.9784 
Average 0.9975 0.9915 0.9945 
RSD% 0.4 0.6 0.9 
The study of the distribution of residuals revealed randomly dispersed shapes around the 
horizontal axis, proving the pertinence of the linear regression model for interpreting the data.  
The received residual plots are reported in Annex 1 (Figure 2 (CBZ), Figure 4 (CBZ-DiOH) and 
Figure 6 (SMZ)). 
3.3.1.1. Extension of the calibration for CBZ, CBZ-DiOH and SMZ analysis 
The upper limit of the calibration curve was initially set at 100 ng/L. However, in order to be able 
to quantify real water samples with analytes concentration above this reported upper limit of the 
calibration curve (100 ng/L), an extended calibration curve (up to 2000 ng/L) was evaluated. A 
blank sample spiked only with labelled internal standard and six spiked MilliQ water samples (i.e.: 
0, 0.2, 2, 40, 100, 1000, 2000 ng/L) were extracted and analysed in three replicates on a single 
day basis. Even in the wider concentration range, the coefficient of determination (R2) resulted to 
be >0.99 and the residual plot showed a random distribution against x axis. The calibration curves 
of the extended linearity study are shown in Annex 1, Figure 11.  
3.3.2. Linearity study for TCPP 
For TCPP the linearity was studied in the concentration range 0-500 ng/L. 
In order to verify the linearity of the calibration curve, a blank sample spiked only with labelled 
internal standard and five spiked MilliQ water samples (i.e.: 0, 10, 25, 50, 200 and 500 ng/L) were 
extracted and analysed in three replicates on eight different days. The received calibration curves 
are shown in Annex 1, Figure 7. 
The linearity of the calibration plots was estimated by calculating the regression coefficient R2 and 
by checking the shape of distribution of residuals. The calculated R2 values were ≥0.99 for all 
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calibration curves (see Table 9) and the residuals were randomly dispersed around the horizontal 
axis (see the residual plots for TCPP in the Annex 1, Figure 8).  
Table 9 Coefficient of determination (R2) values for TCPP calibration curves on different days 
Validation day TCPP 
1 0.9947 
2 0.9999 
3 1.0000 
4 0.9989 
5 0.9990 
6 0.9996 
7 0.9999 
8 0.9992 
Average 0.9989 
RSD % 0.18% 
 
The linear regression model proved to be appropriate for interpreting the data. 
3.3.2.1. Extension of the calibration for TCPP analysis 
According to the information received from scientific literature (Andresen, et al., 2004; Bollmann, 
et al., 2012; Regnery, et al., 2010) the linearity of the method was first tested in the 
concentration range from 0 ng/L to 500 ng/L as described in the paragraph 3.3.2. After finalising 
the measurements of the real samples it was realised that around 15% of the results were 
exceeding the concentration of the maximum calibration point. In order to check the linearity of 
the method in higher concentration level, additional experiments were carried out and the linearity 
study was extended to 3000 ng/L by analysing 6 calibration solutions with concentrations 10, 50, 
200, 750, 1500 and 3000 ng/L. The calibration solutions were prepared by spiking 1L of MilliQ 
water with native TCPP and extracted by SPE like real samples. 
Also in this case the established R2 value was >0.99. It can be stated, that inside the tested 
concentration range the method is linear. The calibration curve of the extended linearity study is 
shown in the in Annex 1, Figure 11.  
3.3.3. Linearity study for PFPrA 
For PFPrA the linearity was studied in the concentration range 1-200 ng/L. 
In order to verify the linearity of the calibration curve, a blank sample spiked only with labelled 
internal standard and six spiked MilliQ water samples (i.e.: 0, 1, 5, 10, 20, 100, 200 ng/L) were 
extracted and analysed in three replicates on five different days.  
The received calibration curves are reported in Annex 1, Figure 9.  
The mean R2 values (calculated over five calibration curves) were ≥0.99. Results are reported in 
Table 10. 
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Table 10 Coefficient of determination (R2) values for PFPrA calibration curves on different days 
Validation day PFPrA 
1 0.9990 
2 0.9990 
3 0.9970 
4 0.9970 
5 0.9980 
Average R2 0.9980 
RSD% 0.1 
The study of the distribution of residuals revealed randomly dispersed shapes around the 
horizontal axis, proving the pertinence of the linear regression model for interpreting the data.  
The received residual plots are reported in Annex 1, Figure 10. 
3.4. Working Range 
The working range is defined as the range of concentrations where the chosen calibration curve is 
valid. The working range of these methods was therefore defined by the limits of quantification 
and highest points in the respective calibration curve. Table 11 summarizes the working ranges 
established for the developed procedures. 
Table 11 Working ranges of the analytes 
Analyte Working range (ng/L) 
CBZ 0.07-2000 
CBZ-DiOH 0.26-2000 
SMZ 0.13-2000 
TCPP 4.0-3000 
PFPrA 1.0-200 
3.5. Trueness 
The significance test (e.g. t-test) was used to decide whether the difference between the mean 
values of spiked water quality control samples (evaluated on n replicates) and their nominal 
concentration was significant, using the following formula: 
 
where (x) is the mean value of (n) samples with standard deviation (s) and (µ) is the nominal 
concentration. The confidence level for critical t-values were chosen to be 0,05 (95%). 
3.5.1. CBZ, CBZ-DiOH and SMZ 
Fifteen quality control samples at low and high concentration levels (i.e.: spiked at about 3 and 90 
ng/L) were extracted and analysed and the back calculated concentrations (using internal 
surrogate standards) evaluated for demonstrating the truthfulness of the null hypothesis (H0: the 
analytical method is not subject to systematic error). 
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3.5.2. TCPP 
Eight spiked water samples with concentration of 30 ng/L and eight spiked water samples with 
concentration of 300 ng/L were analysed and the back calculated concentrations evaluated for 
demonstrating the truthfulness of the null hypothesis (H0: the analytical method is not subject to 
systematic error). 
3.5.3. PFPrA 
Fifteen quality control samples at low and high concentration level (i.e.: spiked at about 3 and 150 
ng/L) were extracted and analysed and the back calculated concentrations evaluated for 
demonstrating the truthfulness of the null hypothesis (H0: the analytical method is not subject to 
systematic error). 
As reported in Table 12, the calculated t-values resulted to be lower than the critical values for all 
the analytes at all the studied concentration levels, demonstrating the absence of evidence of 
systematic errors in analyte quantification.  
Table 12 Results of the trueness study in the different concentration levels 
Analyte 
Mean 
value 
(x) 
ng/L 
Nr of 
samples 
(n) 
Nr of 
degrees 
of 
freedom 
Theoretical 
value (µ) 
ng/L 
SD of 
samples 
(s) ng/L 
Calculated 
t-value 
Critical 
t₄ 
P=0.05 
Decision 
CBZ 
3.2 15 14 3.1 0.43 1.09 2.14 OK 
91.3 15 14 93.6 10.4 -0.87 2.14 OK 
CBZ-DiOH 
2.9 15 14 2.9 0.378 0.10 2.14 OK 
91.8 15 14 88.2 9.694 1.44 2.14 OK 
SMZ 
3.5 15 14 3.4 0.378 0.82 2.14 OK 
104.5 15 14 101.7 9.694 1.12 2.14 OK 
TCPP 
34.1 8 7 30 5.33 2.19 2.36 OK 
324 7 6 300 37.37 1.71 2.36 OK 
PFPrA 
3.1 15 14 3 0.25 0.96 2.14 OK 
150.1 15 14 150 11.98 0.02 2.14 OK 
3.6. Recovery 
Recovery was evaluated by extracting and analysing in triplicate MilliQ water samples (1 L volume 
for CBZ, CBZ-DiOH, SMZ, TCPP and 0.1 L volume for PFPrA) spiked, before extraction, with native 
analytes only. Internal standards were then added to the extracts at the end of sample preparation 
with the aim to allow the estimation of analytes loss during processing. 
The recovery was evaluated comparing the ratios analyte/IS in spiked samples to the same ratios 
obtained by analysing a standard solution containing native compounds and labelled ones at the 
same concentration levels, not subject to any handling.  
The spiking levels were 3 and 90 ng/L for CBZ, CBZ-DiOH, and SMZ, 30 and 300 ng/L for TCPP 
and 30 and 150 ng/L for PFPrA.  
The results of recovery experiments are reported in Table 13. 
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Table 13 Recovery of analytes at different concentration levels 
Analyte Spike level 
Mean Recovery (%) 
(n=9) 
SD 
(ng/L) RSD% 
CBZ 
Low 84 4.0 4.7 
High 88 2.0 2.3 
CBZ-DiOH 
Low 74 5.7 7.6 
High 85 5.1 6 
SMZ 
Low 74 12.1 16.3 
High 97 9.2 9.5 
TCPP 
Low 126 2.3 1.8 
High 106 2.9 2.7 
PFPrA 
Low 120 15.3 12.7 
High 95 7.2 7.5 
3.7. Repeatability, intermediate precision, and day to day variation 
For repeatability, intermediate precision and day to day variation estimation, quality control 
samples at two concentration levels (i.e. spiked MilliQ water samples) were tested on five different 
days. For each sample three replicate injections were made. Using one-way ANOVA the results 
were obtained as shown in Table 14. 
Table 14 Repeatability, day-to-day and intermediate precision variation in two different 
concentration levels 
Analyte 
Lower concentration level Higher concentration level 
Repeatability (%) 
Day-to-
day 
variation 
(%) 
Intermediate 
precision (%) Repeatability (%) 
Day-to-
day 
variation 
(%) 
Intermediate 
precision   
(%) 
CBZ 3.7 13.6 14.1 9.4 7.0 11.7 
CBZ-DiOH 3.2 13.4 13.8 2.7 1.0 2.9 
SMZ 11.2 9.0 14.4 7.6 8.1 11.2 
TCPP 2.5 6.5 6.9 1.1 5.9 6.0 
PFPrA 8.1 6.5 2.4 7.9 11.4 13.8 
3.8. Sample storage stability study 
Stability of analytes in water samples during storage was studied by analysing low and high QC 
samples (spiked MilliQ water), prepared on August 03, 2012 and stored at identical temperature 
and lighting conditions (i.e.: +5˚C, darkness) as the real water samples.  
Stability samples for CBZ, CBZ-DIOH and SMZ were extracted and analysed on day 0, 38, 83 and 
96 after spiking.Stability samples for TCPP were extracted and analysed after 40, 84 and 97 days. 
Concentrations in stability samples fall within ± 2 times the standard deviation of the 
concentrations of quality control samples used for repeatability evaluation.  
The stability study covers the time elapsed from the collection of the first sample to the end of the 
analytical work of the project.  
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It was concluded that all target analytes are stable under the storage conditions.  
A graphical representation of stability data is reported in Annex 1, Figure 12 (for CBZ, CBZ-DiOH, 
SMZ) and Figure 13 (for TCPP).  
3.9. Uncertainty estimation 
The estimation of measurement uncertainty was carried out following an alternative (“top-down”) 
approach based on in-house validation data. The data derived from the validation of the method 
includes the sample preparation, standard dilution, and chromatographic and MS detection 
variability, measured as RSD (relative standard deviation). According to this approach the two 
main sources of uncertainty are method trueness and precision. The uncertainty of prepared 
standard stock solution is taken into account as other source of uncertainty. The expanded 
uncertainty was calculated using the following formula: 
, where: 
uPrec is standard relative uncertainty associated to the precision and is derived from the relative 
intermediate precision of measurements of QC samples. 
uTness is standard relative uncertainty associated to the trueness and has been calculated from 
relative standard deviation of the mean of QC samples used for the trueness study and relative 
bias as follows: 
, where: 
SD is the standard deviation of the results of QC samples analyses, 
C is the average result of the QC samples analyses,  
n is the number of QC samples that have been analysed and  
CTheor is the theoretical concentration of the QC sample. 
uStd is standard relative uncertainty associated to the used certified materials calculated as follows. 
In case of TCPP analysis: 
, where: 
uTCPP is uncertainty of the certified standard solution of TCPP,  
uIS is the uncertainty of the certified standard solution of TBP-d27,  
uFlask is uncertainty related to the volumetric flask, a rectangular distribution is assumed to obtain 
a standard uncertainty of flask and  
uSyringe is the uncertainty related to the withdrawn of standard solution, from syringe accuracy a 
rectangular distribution is assumed to obtain a standard uncertainty. 
In case of CBZ, CBZ-DiOH and SMZ analysis: 
, where: 
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uFlask is uncertainty related to the volumetric flask, a rectangular distribution is assumed to obtain 
a standard uncertainty of flask and  
ubalance is the uncertainty related to the weighing of crystalline powder, from balance accuracy a 
rectangular distribution is assumed to obtain a standard uncertainty. 
k is correlation coefficient (k=2). 
As the precision and trueness of the method were estimated in two different concentration levels, 
the uncertainty can also be estimated separately for the low and high concentration levels. 
The detailed uncertainty budgets and results of the uncertainty estimations are reported in Table 
15 (for CBZ, CBZ-DiOH and SMZ) in Table 16 (for PFPrA) and Table 17 (for TCPP). 
Table 15 Uncertainty budget and estimated uncertainty for CBZ, CBZ-DiOH and SMZ analysis 
 
CBZ CBZ-DiOH SMZ 
Sources of uncertainty            
 
Abbreviation Unit Low conc. 
High 
conc. 
Low 
conc. 
High 
conc. 
Low 
conc. 
High 
conc. 
Intermediate 
precision  
% 14.1 11.7 13.8 10.4 14.4 16.1 
Standard relative 
uncertainty 
associated to the 
precision 
uPres 
 
0.141 0.117 0.138 0.104 0.144 0.161 
Average 
concentration of 
the QC samples 
C ng/L 3.24 91.26 2.95 100.35 3.47 110.35 
Standard 
deviation of the 
QC samples 
SD ng/L 0.45 8.07 0.4 10.1 0.38 14.12 
Number of the QC 
samples n  
15 15 15 15 15 15 
Theoretical 
concentration of 
the QC sample 
CTheor ng/L 3.12 93.6 2.94 98 3.39 113 
Standard relative 
uncertainty 
associated to the 
trueness 
uTness 
 
0.07 0.042 0.06 0.08 0.054 0.044 
Standard relative 
uncertainty 
associated to 
crystalline 
standard weighing 
uBalance 
 
0.07 0.07 0.07 0.07 0.07 0.07 
Accuracy of the 
volumetric flask  
mL 0.04 0.04 0.04 0.04 0.04 0.04 
Standard relative 
uncertainty 
associated to the 
accuracy of the 
volumetric flask 
uFlask 
 
0.0231 0.0231 0.231 0.231 0.231 0.231 
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Standard relative 
uncertainty 
associated to the 
preparation of the 
standard stock 
solution 
uStd  0.074 0.074 0.074 0.074 0.074 0.074 
Correlation 
coefficient k  2 2 2 2 2 2 
Expanded 
combined relative 
uncertainty 
Uc % 35 39 34 31 34 36 
Table 16 Uncertainty budget and estimated uncertainty for PFPrA analysis 
Sources of uncertainty Abbreviations Unit 
Low 
concentration 
level 
High 
concentration 
level 
Intermediate precision  % 10.4 13.8 
Standard relative uncertainty 
associated to the precision uPres  0.104 0.138 
Average concentration of the 
QC samples C ng/L 3.06 150.07 
Standard deviation of the QC 
samples SD ng/L 0.305 14.931 
Number of the QC samples n  15 15 
Theoretical concentration of 
the QC sample CTheor  3 150 
Standard relative uncertainty 
associated to the trueness uTness  0.031 0.034 
Standard relative uncertainty 
associated to standard 
weighing 
uBalance  0.07 0.07 
Accuracy of the volumetric 
flask  mL 0.04 0.04 
Standard relative uncertainty 
associated to the accuracy of 
the volumetric flask 
uFlask  0.0231 0.0231 
Standard relative uncertainty 
associated to the preparation 
of the standard stock solution 
uStd  0.074 0.074 
Correlation coefficient k  2 2 
Expanded combined relative 
uncertainty of the method Uc % 26 36 
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Table 17 Uncertainty budget and estimated uncertainty for TCPP analysis 
Sources of uncertainty Abbrevi-ations Unit Low conc. High conc. 
Intermediate precision 
 
% 6.9 6.0 
Standard relative uncertainty 
associated to the precision uPres  
0.069 0.060 
Average concentration of the QC 
samples C ng/L 34.04 324.16 
Standard deviation of the QC 
samples SD ng/L 5.39 37.37 
Number of the QC samples n 
 
8 7 
Theoretical concentration of the QC 
sample CTheor ng/L 30 300 
Standard relative uncertainty 
associated to the trueness uTness  
0.1312 0.0863 
Guaranteed accuracy of the TCPP 
certified standard solution  
% 0.5 0.5 
Standard relative uncertainty 
associated to the accuracy of the 
standard of TCPP 
uTCPP 
 
0.005 0.005 
Uncertainty in the preparation of the 
TBP-d27 certified standard solution uIS  
0.05 0.05 
Accuracy of the volumetric flask 
 
mL 0.04 0.04 
Standard relative uncertainty 
associated to the accuracy of the 
volumetric flask 
uFlask 
 
0.0231 0.0231 
Accuracy of the syringe 
 
% 1 1 
Standard relative uncertainty 
associated to the accuracy of the 
syringe 
uSyringe 
 
0.0058 0.0058 
Standard relative uncertainty 
associated to the preparation of the 
standard stock solution 
uStd 
 
0.0565 0.0565 
Correlation coefficient k 
 
2 2 
Expanded combined relative 
uncertainty of the method Uc % 32 24 
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ANNEX 1 
Figure 1 Calibration curves of CBZ 
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Figure 2 Residual plots of CBZ 
 
 33 
 
Figure 3 Calibration curves of CBZ-DiOH 
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Figure 4 Residual plots of CBZ-DiOH 
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Figure 5 Calibration curves of SMZ 
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Figure 6 Residual plots of SMZ 
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Figure 7 Calibration curves of TCPP 
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Figure 8 Residual plots of TCPP 
!
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Figure 9 Calibration curves of PFPrA 
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Figure 10 Residual plots of PFPrA 
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Figure 11 Extended calibration curves 
!
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Figure 12 Results of CBZ, CBZ-DiOH and SMZ stability studies 
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Figure 13 Results of TCPP stability study 
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